2019 Inter-CFAR Women and HIV Symposium


The goal of the Inter-CFAR Women and HIV Symposium is to identify gaps in knowledge in HIV and women’s research and develop strategies that will move the field forward. We aim to generate collaborative activity between CFARs and other research networks, highlighting cutting edge science and promoting opportunities for early career investigators. The 2019 symposium will feature breakout meetings with senior investigators and networking opportunities each day.

Symposium Agenda At-A-Glance

Day One

7:30 a.m. Registration Opens, Poster Set Up, and Continental Breakfast

8:00 a.m. Opening Session

  • Welcome from Chair of the HIV in Women Working Group
    Phyllis Tien, UCSF-Gladstone CFAR
  • Community Address
    Maya Green, Howard Brown Health
  • Keynote Adress
    Thomas Hope, Northwestern University / Third Coast CFAR

9:00 a.m. Plenary 1 — Hormones, hormones, hormones

  • Clinical trials: ECHO results 
    Jared Baeten, UW/Fred Hutch CFAR
  • Basic Research: Hormones and the Mucosal Environment
    Adam Burgener, University of Manitoba
  • Sociobehavioral Research: Impact of HC on Women’s Health in Resource Poor Settings
    Margaret Kasaro, UNC Global Projects Zambia, UNC CFAR

10:35 a.m. Oral Abstract Presentations

  • Hormonal contraception and women’s HIV acquisition risk in Rwandan discordant couples, 2002-2011 
    Kristin Wall, Emory University CFAR
  • Experiences of side effects among new contraceptive implant users concomitantly using efavirenz- or dolutegravir-containing
    Randy Stalter, UW/Fred Hutch CFAR
  • Tailoring a gender-specific HIV cure strategy using NK cells expanded ex vivo
    Mary Ann Checkley, Case Western Reserve CFAR
  • Distribution of I.V. injected Cu64, Zr89, and fluorescently labeled VRC01 and VRC01-LS in the in vivo Rhesus Macaque Model
    Ann Carias, Northwestern University / Third Coast CFAR

12:10 p.m. Networking Mentoring Lunch

1:20 p.m. Plenary 2 — Long Acting ARV formulations for treatment and prevention: Are there sex differences?

  • Clinical Research: Sex differences in LA-CBV
    Kim Smith, ViiV Healthcare
  • Clinical Trials: New clinical trials in LA-ARV; Long acting ARVs in Non-Adherent populations
    Aadia Rana, UAB CFAR
  • Sociobehavioral: Acceptability of long-acting ARV formulations in MSM populations
    Bob Schieffer, Northwestern University CFAR
  • Sociobehavioral: Acceptability of long-acting ARV formulations in young women in SSA
    Ariane Van der Stratten, UCSF-Gladstone CFAR

3:25 p.m. Oral Abstract Presentations

  • Controlled Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP)
    Linying Alice Li, RTI / UNC CFAR
  • Development of Subcutaneous Biodegradable Implants Comprised of Long-Acting (LA) Antiretroviral (ARV) and Hormonal Contraceptive
    Archana Krovi, RTI / UNC CFAR
  • Shots don’t bother me: how a history of injectable medication and/or substance use impact HIV-positive women’s attitudes toward, and willingness to use, long-acting injectable antiretroviral therapy
    Morgan Philibin, Columbia University

4:30 p.m. The Value of Cross-Disciplinary Research to End the HIV Epidemic

  • Welcome from Third Coast CFAR Director
    Richard D’Aquila, Northwestern University / Third Coast CFAR
  • Remaking a Life: How Women With HIV/AIDS Confront Inequality
    Celeste Watkins-Hayes, Northwestern University / Third Coast CFAR

5:00 – 7:00 p.m. Poster Abstract Presentations and Reception
Hors d’oeuvres, wine, and beer will be served

Day Two

8:15 a.m. Continental Breakfast

8:40 a.m. Opening Remarks Susan Cu-Uvin, Brown University / Providence-Boston CFAR

8:45 a.m. Plenary 3 — Optimization of Pre-Exposure Prophylaxis in Cis and Trans Women and Men

  • Overview of PrEP Efficacy, Adherence, and Delivery in Cisgender Women
    Lisa Hirschhorn, Northwestern University, Third Coast CFAR
  • Overview of PrEP Efficacy, Adherence, and Delivery in Cisgender Men
    Al Liu, SFDPH Bridge HIV / UCSF-Gladstone CFAR
  • Overview of PrEP Efficacy, and Delivery in Transgender Populations
    Jae Sevelius, UCSF-Gladstone CFAR
  • Basic Science: Mechanisms of Sex Difference in PrEP function
    MacKenzie Cottrell, UNC CFAR
  • Clinical Trial: Dapivirine Ring Progress
    Sharon Hillier, University of Pittsburgh

11:00 a.m. Oral Abstract Presentations

  • Understanding PrEP Persistence among Ciswomen & Transgender Patients
    Maria Pyra, Howard Brown Health
  • Para mi Misma: Providing PrEP in combination with gender affirming care in a community-based setting for trans Latinas
    Sophia Zamudio-Haas, UCSF-Gladstone CFAR
  • Assessing the implications of a hormonal contraceptive in a multipurpose prevention implant for unintended pregnancy and HIV prevention: Qualitative insights from South Africa and Zimbabwe
    Mary Kate Shapley-Quinn, RTI / UNC CFAR

12:15 p.m. Networking Mentoring Lunch

1:30 p.m. Closing Talks

1:45 p.m. Group Mentorship Session for Early Career Investigators

  • How to Get Your Work Noticed: Engaging Policy Makers and Media
    Brian Mustanski, Third Coast CFAR
  • Tips and Resources for Early Career Investigators: A Panel with Representatives from NIH
    Denise Russo, NICHD; Natalie Tomitch, OAR; Joana Roe, NIAID; Samantha Calabrese, NICHD

3:00 p.m. Symposium Concludes

  • Remove Posters from LaSalle Ballroom II

Registration (Closed Sept 19)

Meeting Venue and Lodging

Ground Transportation

Popular Attractions in Chicago (PDF)

Support for Early Career Investigators

Planning Committee

Phyllis Tien, MD
University of California, San Francisco
UCSF-Gladstone CFAR

Renee Heffron, PhD, MPH
University of Washington
UW/Fred Hutch CFAR

Thomas Hope, PhD
Northwestern University
Third Coast CFAR

Susan Cu-Uvin, MD
Brown University
Providence Boston CFAR

Susan Cohn, MD, MPH
Northwestern University
Third Coast CFAR

Roslyn Taylor, PhD
Northwestern University
Third Coast CFAR

Richard D’Aquila, MD
Northwestern University
Third Coast CFAR


Justin Schmandt, Third Coast CFAR

Abstract Competition
Lauren Sterling, UCSF-Gladstone CFAR